For instance, to facilitate the study on how the loss of UBE3A, which regulates synaptic development, in neurons leads to Angelman syndrome, in vitro and in vivo (rat) models were generated by knocking out UBE3A using CRISPR. Here, UBE3A is linked to Angelman syndrome.